Key Insights
The European diabetic care devices market, valued at €8.03 billion in 2025, is projected to experience robust growth, driven by rising prevalence of diabetes, an aging population, and increasing awareness of advanced diabetes management technologies. The market's Compound Annual Growth Rate (CAGR) of 6.18% from 2025 to 2033 indicates significant expansion. Key growth drivers include the rising adoption of continuous glucose monitoring (CGM) systems, offering real-time glucose data for better disease management, and the increasing preference for insulin pumps over traditional injection methods, improving patient convenience and treatment efficacy. Technological advancements in areas like minimally invasive insulin delivery systems and sophisticated data analytics integrated with connected devices are further propelling market growth. However, the high cost of advanced devices, particularly CGMs and insulin pumps, remains a significant restraint, particularly impacting accessibility for patients in certain socioeconomic groups. Furthermore, potential regulatory hurdles and reimbursement challenges for novel technologies can impact market penetration.
Europe Diabetic Care Devices Market Market Size (In Billion)
Market segmentation reveals significant growth potential within various device categories. Continuous glucose monitoring (CGM) devices are experiencing rapid expansion due to their improved accuracy and convenience. Self-monitoring blood glucose (SMBG) devices, while mature, still constitute a substantial segment due to their cost-effectiveness. The insulin delivery segment, encompassing insulin pumps, pens, and injection systems, is also expected to grow significantly, fueled by technological improvements and rising patient preference for convenient and less invasive methods. Germany, France, the United Kingdom, and Italy are expected to be the major contributors to the overall market size within the European region due to their higher prevalence of diabetes and advanced healthcare infrastructure. The "Rest of Europe" segment, comprising smaller countries, will also exhibit growth, albeit at a potentially slower pace, reflecting variations in healthcare spending and diabetes prevalence across the region.
Europe Diabetic Care Devices Market Company Market Share
Europe Diabetic Care Devices Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Europe Diabetic Care Devices Market, offering valuable insights for stakeholders across the industry. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report presents a robust overview of market trends, competitive dynamics, and future growth potential. The report covers key segments including Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, and Jet Injectors. Key players analyzed include Rossmax, Agamatrix Inc, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, LifeScan, Medtronic, Dexcom Inc, Ascensia Diabetes Care, and Insulet Corporation. The report uses Million (M) for all monetary values.
Europe Diabetic Care Devices Market Market Structure & Competitive Dynamics
The Europe Diabetic Care Devices market exhibits a moderately concentrated structure, with a few major players holding significant market share. The competitive landscape is characterized by intense rivalry, driven by ongoing innovation and product differentiation. The regulatory framework, particularly concerning CE marking and reimbursement policies across various European countries, plays a crucial role in shaping market dynamics. The market witnesses continuous innovation, particularly in continuous glucose monitoring (CGM) and insulin delivery systems. Significant mergers and acquisitions (M&A) activity has been observed, with deal values exceeding xx Million in the past five years. These M&A activities, primarily driven by market consolidation and expansion strategies, have further reshaped the competitive landscape. End-user trends are shifting towards more convenient, user-friendly, and integrated devices. For instance, the preference for CGM systems over self-monitoring blood glucose (SMBG) devices is growing steadily.
Europe Diabetic Care Devices Market Industry Trends & Insights
The Europe Diabetic Care Devices market is experiencing robust growth, driven by several key factors. The rising prevalence of diabetes across Europe, coupled with an aging population, is a significant market driver. Technological advancements, such as the development of advanced CGM systems and smart insulin delivery devices, are further fueling market expansion. Consumer preferences are evolving towards more accurate, convenient, and less invasive monitoring and management solutions. The market demonstrates a strong Compound Annual Growth Rate (CAGR) of xx% during the forecast period. Market penetration of CGM devices is increasing rapidly, driven by improved accuracy and convenience. Competitive dynamics are characterized by intense innovation, strategic partnerships, and the emergence of new players offering innovative products and services. The market is also witnessing a growing adoption of digital health technologies, with mobile apps and remote monitoring becoming increasingly prevalent.
Dominant Markets & Segments in Europe Diabetic Care Devices Market
- Germany: Remains the leading market in Europe due to high diabetes prevalence, advanced healthcare infrastructure, and robust reimbursement policies.
- United Kingdom: Significant market share owing to the large diabetic population and increasing adoption of advanced devices.
- France: Strong market growth fueled by government initiatives to improve diabetes care and growing awareness.
- Italy: Market growth is propelled by increasing diabetes prevalence and investments in healthcare infrastructure.
- Spain: Experiences moderate growth driven by rising diabetes cases and the adoption of innovative solutions.
Dominant Segments:
- Continuous Glucose Monitoring (CGM) Devices: The fastest-growing segment, driven by technological advancements and increased patient preference for real-time glucose monitoring. The segment benefits from the introduction of new solutions such as Dexcom ONE+
- Insulin Pumps: This segment demonstrates steady growth driven by improved technology and convenience for insulin management.
- Self-monitoring Blood Glucose (SMBG) Devices: While still a significant market segment, its growth is being outpaced by CGM devices.
Several factors contribute to market dominance, including favorable government policies, well-established healthcare infrastructure, higher disposable income, and greater awareness of diabetes management.
Europe Diabetic Care Devices Market Product Innovations
Recent years have witnessed significant innovation in the European diabetic care devices market. The introduction of advanced CGM systems with improved accuracy, smaller sensor sizes, and longer wear times has significantly enhanced patient experience. Smart insulin delivery systems integrating CGM data with automated insulin delivery are revolutionizing diabetes management. These innovations improve glycemic control, reduce hypoglycemic events, and enhance overall patient outcomes. Continuous development of minimally invasive and user-friendly devices caters to the growing demand for ease of use and convenience.
Report Segmentation & Scope
The report segments the Europe Diabetic Care Devices market based on several parameters:
1. Monitoring Devices:
- Self-monitoring Blood Glucose Devices (SMBG): This segment is characterized by a mature market with competition focused on accuracy, ease of use, and cost-effectiveness. Market size is projected at xx Million by 2033.
- Continuous Glucose Monitoring Devices (CGM): This rapidly expanding segment is dominated by advanced technologies and features. Market size is projected at xx Million by 2033.
2. Management Devices:
- Insulin Pumps: This segment shows steady growth driven by technological advancements and improved patient outcomes. Market size is projected at xx Million by 2033.
- Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, and Jet Injectors: These segments constitute a significant portion of the market, with growth primarily driven by the increasing number of patients requiring insulin therapy. Market size is projected at xx Million by 2033.
3. Lancets: This segment is intrinsically linked to SMBG device usage, and growth is dependent on that market. Market size is projected at xx Million by 2033.
Key Drivers of Europe Diabetic Care Devices Market Growth
Several factors contribute to the robust growth of the Europe Diabetic Care Devices market. The increasing prevalence of diabetes, particularly type 2 diabetes, is a major driver. Technological advancements, resulting in more accurate, convenient, and integrated devices, are also fueling market expansion. Furthermore, supportive government policies and reimbursement schemes incentivize the adoption of advanced diabetes management solutions. Finally, growing awareness of diabetes and its potential complications among the population also promotes market growth.
Challenges in the Europe Diabetic Care Devices Market Sector
The Europe Diabetic Care Devices market faces several challenges. High costs associated with advanced devices, particularly CGM systems and insulin pumps, can hinder market accessibility. Strict regulatory requirements and reimbursement processes can impede the timely launch of new products. Intense competition among established players and the emergence of new entrants can impact market share and profitability. Supply chain disruptions, as seen in recent years, could also impact product availability and cost.
Leading Players in the Europe Diabetic Care Devices Market Market
- Rossmax
- Agamatrix Inc
- Roche Diabetes Care
- Bionime Corporation
- Sanofi
- Eli Lilly
- Novo Nordisk A/S
- Abbott Diabetes Care
- LifeScan
- Medtronic
- Dexcom Inc
- Ascensia Diabetes Care
- Insulet Corporation
Key Developments in Europe Diabetic Care Devices Market Sector
- February 2024: Dexcom launched its real-time CGM solution, Dexcom ONE+, in Europe. This launch is expected to significantly impact market share in the CGM segment.
- June 2022: Cequr released its Insulin Pen 2.0™, a wearable insulin delivery device with an integrated blood glucose meter. This innovation is expected to disrupt the insulin delivery segment.
Strategic Europe Diabetic Care Devices Market Market Outlook
The Europe Diabetic Care Devices market presents significant growth opportunities. Further advancements in CGM technology, particularly in non-invasive sensing and automated insulin delivery, hold immense potential. The growing adoption of digital health technologies and telehealth platforms will further enhance market growth. Strategic partnerships and collaborations between device manufacturers, healthcare providers, and technology companies will play a crucial role in shaping the future of the market. The increasing focus on personalized medicine and remote patient monitoring will create new avenues for growth and innovation.
Europe Diabetic Care Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable Pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
Europe Diabetic Care Devices Market Segmentation By Geography
- 1. France
- 2. Germany
- 3. Italy
- 4. Spain
- 5. United Kingdom
- 6. Russia
- 7. Rest of Europe
Europe Diabetic Care Devices Market Regional Market Share
Geographic Coverage of Europe Diabetic Care Devices Market
Europe Diabetic Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.18% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Digital Dentistry
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable Pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. France
- 5.3.2. Germany
- 5.3.3. Italy
- 5.3.4. Spain
- 5.3.5. United Kingdom
- 5.3.6. Russia
- 5.3.7. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring Devices
- 6.1.2.1. Sensors
- 6.1.2.2. Durables (Receivers and Transmitters)
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable Pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring Devices
- 7.1.2.1. Sensors
- 7.1.2.2. Durables (Receivers and Transmitters)
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable Pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring Devices
- 8.1.2.1. Sensors
- 8.1.2.2. Durables (Receivers and Transmitters)
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable Pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Spain Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring Devices
- 9.1.2.1. Sensors
- 9.1.2.2. Durables (Receivers and Transmitters)
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable Pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring Devices
- 10.1.2.1. Sensors
- 10.1.2.2. Durables (Receivers and Transmitters)
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable Pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Russia Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.1.1.1. Glucometer Devices
- 11.1.1.2. Blood Glucose Test Strips
- 11.1.1.3. Lancets
- 11.1.2. Continuous Glucose Monitoring Devices
- 11.1.2.1. Sensors
- 11.1.2.2. Durables (Receivers and Transmitters)
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.2. Market Analysis, Insights and Forecast - by Management Devices
- 11.2.1. Insulin Pump
- 11.2.1.1. Insulin Pump Device
- 11.2.1.2. Insulin Pump Reservoir
- 11.2.1.3. Infusion Set
- 11.2.2. Insulin Syringes
- 11.2.3. Cartridges in Reusable Pens
- 11.2.4. Insulin Disposable Pens
- 11.2.5. Jet Injectors
- 11.2.1. Insulin Pump
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.1.1.1. Glucometer Devices
- 12.1.1.2. Blood Glucose Test Strips
- 12.1.1.3. Lancets
- 12.1.2. Continuous Glucose Monitoring Devices
- 12.1.2.1. Sensors
- 12.1.2.2. Durables (Receivers and Transmitters)
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.2. Market Analysis, Insights and Forecast - by Management Devices
- 12.2.1. Insulin Pump
- 12.2.1.1. Insulin Pump Device
- 12.2.1.2. Insulin Pump Reservoir
- 12.2.1.3. Infusion Set
- 12.2.2. Insulin Syringes
- 12.2.3. Cartridges in Reusable Pens
- 12.2.4. Insulin Disposable Pens
- 12.2.5. Jet Injectors
- 12.2.1. Insulin Pump
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2025
- 13.2. Company Profiles
- 13.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 Agamatrix Inc
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Self-monitoring Blood Glucose Devices
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Roche Diabetes Care
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Bionime Corporation
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Sanofi
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 Eli Lilly
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Novo Nordisk A/S
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Abbott Diabetes Care
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.10 LifeScan
- 13.2.10.1. Overview
- 13.2.10.2. Products
- 13.2.10.3. SWOT Analysis
- 13.2.10.4. Recent Developments
- 13.2.10.5. Financials (Based on Availability)
- 13.2.11 Medtronic
- 13.2.11.1. Overview
- 13.2.11.2. Products
- 13.2.11.3. SWOT Analysis
- 13.2.11.4. Recent Developments
- 13.2.11.5. Financials (Based on Availability)
- 13.2.12 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 13.2.12.1. Overview
- 13.2.12.2. Products
- 13.2.12.3. SWOT Analysis
- 13.2.12.4. Recent Developments
- 13.2.12.5. Financials (Based on Availability)
- 13.2.13 Insulin Device
- 13.2.13.1. Overview
- 13.2.13.2. Products
- 13.2.13.3. SWOT Analysis
- 13.2.13.4. Recent Developments
- 13.2.13.5. Financials (Based on Availability)
- 13.2.14 Dexcom Inc
- 13.2.14.1. Overview
- 13.2.14.2. Products
- 13.2.14.3. SWOT Analysis
- 13.2.14.4. Recent Developments
- 13.2.14.5. Financials (Based on Availability)
- 13.2.15 Continuous Glucose Monitoring Devices
- 13.2.15.1. Overview
- 13.2.15.2. Products
- 13.2.15.3. SWOT Analysis
- 13.2.15.4. Recent Developments
- 13.2.15.5. Financials (Based on Availability)
- 13.2.16 Ascensia Diabetes Care
- 13.2.16.1. Overview
- 13.2.16.2. Products
- 13.2.16.3. SWOT Analysis
- 13.2.16.4. Recent Developments
- 13.2.16.5. Financials (Based on Availability)
- 13.2.17 Insulet Corporation
- 13.2.17.1. Overview
- 13.2.17.2. Products
- 13.2.17.3. SWOT Analysis
- 13.2.17.4. Recent Developments
- 13.2.17.5. Financials (Based on Availability)
- 13.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
List of Figures
- Figure 1: Europe Diabetic Care Devices Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: Europe Diabetic Care Devices Market Share (%) by Company 2025
List of Tables
- Table 1: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 2: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 3: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2020 & 2033
- Table 4: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 5: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 6: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 7: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 8: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 9: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 10: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 11: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 12: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 13: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 14: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 15: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 17: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 18: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 19: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 20: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 21: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 22: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 23: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 24: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Diabetic Care Devices Market?
The projected CAGR is approximately 6.18%.
2. Which companies are prominent players in the Europe Diabetic Care Devices Market?
Key companies in the market include Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Agamatrix Inc, Self-monitoring Blood Glucose Devices, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, LifeScan, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Insulin Device, Dexcom Inc, Continuous Glucose Monitoring Devices, Ascensia Diabetes Care, Insulet Corporation.
3. What are the main segments of the Europe Diabetic Care Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 8.03 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost Associated with the Digital Dentistry.
8. Can you provide examples of recent developments in the market?
Feburary 2024: Dexcom launched real-time CGM solution Dexcom ONE+ in Europe. Dexcom ONE+ is a customisable continuous glucose monitoring solution that can be worn at three different location on the body.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Diabetic Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Diabetic Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Diabetic Care Devices Market?
To stay informed about further developments, trends, and reports in the Europe Diabetic Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence